CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Hikma Pharmaceuticals USA Inc. recalls Lorazepam Injection

Read the official FDA notice

Published
6 Aug 2025
Units affected
382,775 1mL vials
Agency
FDA
Country
United States

The hazard

Failed Impurities/Degradation Specifications: An out-of-Specification for total related compounds

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Lorazepam Injection, USP, 2 mg/mL, 25 x 1mL vials/carton, Rx Only, Manufactured by: Hikma Berkeley Heights, NJ 07922, NDC# 0641-6044-25

Brand / company
Hikma Pharmaceuticals USA Inc.
Codes / lots
Lot # K24118, exp. date 10/31/2026
Distribution
Distributed Nationwide in the USA
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 6 Aug 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.